Myelodysplastic-Myeloproliferative DiseasesMyelodysplastic SyndromesMastocytosis, SystemicMyeloproliferative DisordersNeoplasms, Second PrimaryLeukemia, Myeloid, AcuteNeoplasm TransplantationLiver TransplantationHematologic NeoplasmsTransplantation, HomologousLeukemia, MyeloidKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationMutationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraImmunosuppressive AgentsTreatment OutcomeTransplantation, IsogeneicGraft vs Host DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationHeart-Lung TransplantationRetrospective StudiesNeoplasmsPancreatic NeoplasmsTissue and Organ ProcurementTransplantation ToleranceTime FactorsPeripheral Blood Stem Cell TransplantationLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationNeoplasms, Cystic, Mucinous, and SerousTransplantation, HeterologousRecurrenceWaiting ListsFollow-Up StudiesMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilitySurvival RateSurvival AnalysisTacrolimusTissue TransplantationLiver NeoplasmsWhole-Body IrradiationCyclosporineSkin NeoplasmsCadaverLeukemiaLiver DiseasesBrain Tissue TransplantationNeoplasms, Multiple PrimaryFacial TransplantationDonor SelectionOrgan PreservationImmunohistochemistryKidney NeoplasmsPrognosisCombined Modality TherapyBusulfanRisk FactorsTransplantsHLA AntigensLymphomaKidney Failure, ChronicBronchiolitis ObliteransFatal OutcomeBiopsyRemission InductionThyroid NeoplasmsAntilymphocyte SerumMice, Inbred C57BLAcute DiseaseAdenocarcinoma, MucinousHematopoietic Stem CellsPostoperative PeriodHand TransplantationAnemia, AplasticLiverCyclophosphamide